Cargando…
Clinical utility of circulating tumor cell counting through CellSearch(®): the dilemma of a concept suspended in Limbo
To date, 10 years after the first demonstration of circulating tumor cells (CTCs), prognostic significance in metastatic breast cancer using the US Food and Drug Administration–cleared system CellSearch(®), the potential utility of CTCs in early clinical development of drugs, their role as a surroga...
Autores principales: | Raimondi, Cristina, Gradilone, Angela, Naso, Giuseppe, Cortesi, Enrico, Gazzaniga, Paola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4000244/ https://www.ncbi.nlm.nih.gov/pubmed/24790460 http://dx.doi.org/10.2147/OTT.S46200 |
Ejemplares similares
-
Molecular markers in circulating tumour cells from metastatic colorectal cancer patients
por: Gazzaniga, Paola, et al.
Publicado: (2010) -
Circulating tumour cells lacking cytokeratin in breast cancer: the importance of being mesenchymal
por: Gradilone, Angela, et al.
Publicado: (2011) -
Clinical Applications of Circulating Tumor Cells in Lung Cancer Patients by CellSearch System
por: Truini, Anna, et al.
Publicado: (2014) -
In vitro detection of circulating tumor cells compared by the CytoTrack and CellSearch methods
por: Hillig, Thore, et al.
Publicado: (2015) -
Counting circulating endothelial cells in allo-HSCT: an ad hoc designed polychromatic flowcytometry-based panel versus the CellSearch System
por: Almici, Camillo, et al.
Publicado: (2019)